Axcella Health Inc. (NASDAQ:AXLA) saw an upside of 39.53% to close Tuesday at $0.60 after adding $0.17 on the day. The 5-day average trading volume is 5,236,800 shares of the company’s common stock. It has gained $0.7521 in the past week and touched a new high 2 times within the past 5 days. An average of 1,440,670 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,379,576.
AXLA’s 1-month performance is 81.76% or $0.2875 on its low of $0.2960 reached on 01/05/23. The company’s shares have touched a 52-week low of $0.16 and high of $2.89, with the stock’s rally to the 52-week high happening on 01/24/23. YTD, AXLA has achieved 83.21% or $0.2725 and has reached a new high 7 times. However, the current price is down -79.24% from the 52-week high price.
AXLA stock investors last saw insider trading activity on Oct 19.Hinshaw William (President & CEO) most recently sold 16,000 shares at $1.56 per share on Oct 19. This transaction cost the insider $25,027. Chief Medical Officer, Koziel Margaret, sold 547 shares at a price of $2.52 on Sep 06. Then, on Jun 01, Chief Medical Officer Koziel Margaret sold 590 shares at a price of $2.01 per share. This transaction amounted to $1,186.
AXLA stock has a beta of 1.23.
Axcella Health Inc.’s quick ratio for the period ended September 29 was 1.20, with the current ratio over the same period at 1.20. The firm’s gross profit as reported stood at $2.92 million against revenue of $61.85 million.
For the quarterly period ending September 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 12.5% to -$17.84 million, while revenue of -$21.31 million was -19.45% off the previous quarter. Analysts expected AXLA to announce -$0.38 per share in earnings in its latest quarter, but it posted -$0.34, representing a 10.50% surprise. EBITDA for the quarter stood at more than -$16.96 million. AXLA stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 38.34 million, with total debt at $21.66 million. Shareholders hold equity totaling $73.56 million.
Let’s look briefly at Axcella Health Inc. (AXLA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 73.34% to suggest the stock is trending Overbought, with historical volatility in this time period at 185.68%.
The stock’s 5-day moving average is $0.4659, reflecting a +34.53% or $0.1540 change from its current price. AXLA is currently trading +75.95% above its 20-day SMA, -75.21% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -29.41% and SMA200 by-77.36%.
Stochastic %K and %D was 60.60% and 60.36% and the average true range (ATR) pointed at 0.0909. The RSI (14) points at 60.18%, while the 14-day stochastic is at 66.65% with the period’s ATR at 0.0905. The stock’s 9-day MACD Oscillator is pointing at 0.0410 and 0.0781 on the 14-day charts.
In the most recent analyst report for Axcella Health Inc. (NASDAQ: AXLA), Noble Capital Markets launched coverage with an Outperform rating. Analysts offering their rating for AXLA stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate AXLA as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is AXLA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.50 and a high of $8.00, with their median price target at $5.50. Looking at these predictions, the average price target given by analysts is for Axcella Health Inc. (AXLA) stock is $5.13.